R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models-Reference-Cited by-同舟云学术

R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models

Published:2021-01-14 Issue:5 Volume:57 Page:2003271
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Awada Charifa,Grobs Yann,Wu Wen-Hui,Habbout Karima,Romanet Charlotte,Breuils-Bonnet Sandra,Tremblay Eve,Martineau Sandra,Paulin Roxane,Bonnet Sébastien,Provencher Steeve,Potus François,Boucherat Olivier

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Endothelial Dysfunction in Pulmonary Hypertension

2. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases

3. Pulmonary arterial hypertension: new pathophysiological insights and emerging therapeutic targets;Bourgeois;Int J Biochem Cell Biol,2018

4. Spatio-Temporal Diversity of Apoptosis Within the Vascular Wall in Pulmonary Arterial Hypertension

5. Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computations for Sustainability;Quantitative Sustainability;2024

2. Metabolic reprogramming: A novel metabolic model for pulmonary hypertension;Frontiers in Cardiovascular Medicine;2022-08-26

3. The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure;Circulation Research;2022-04-29

4. Differentiating pulmonary hypertension associated with protein kinase inhibitors;Pulmonary Circulation;2022-04

5. Crizotinib for ROS1‐rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation;Pulmonary Circulation;2022-01